The perception that the convergence of biological engineering and artificial intelligence (AI) could enable increased biorisk has recently drawn attention to the governance of biotechnology and artificial intelligence. The 2023 Executive Order, Executive Order on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence, requires an assessment of how artificial intelligence can increase biorisk. Within this perspective, quantitative and qualitative frameworks for evaluating biorisk are presented. Both frameworks are exercised using notional scenarios and their benefits and limitations are then discussed. Finally, the perspective concludes by noting that assessment and evaluation methodologies must keep pace with advances of AI in the life sciences.

翻译：生物工程与人工智能（AI）的融合可能加剧生物风险的认知，近期引起了人们对生物技术与人工智能治理的关注。2023年《关于安全、可靠且可信地开发与使用人工智能的行政命令》要求评估人工智能如何增加生物风险。基于这一视角，本文提出了评估生物风险的定量与定性框架。通过假设情景对两种框架进行实践应用，并讨论其优势与局限性。最后，本文指出评估与评价方法必须跟上人工智能在生命科学领域的发展步伐。